## **Core Concept**
The interferon-gamma release assay (IGRA) is a blood test used to diagnose *Mycobacterium tuberculosis* infection. It measures the release of interferon-gamma (IFN-γ) from T cells in response to specific antigens. This assay helps in detecting latent tuberculosis infection.

## **Why the Correct Answer is Right**
The correct answer, **ESAT-6, CFP-10, and TB7.7**, are specific antigens used in the IGRA. These antigens, particularly ESAT-6 (Early Secretory Antigenic Target of 6 kDa) and CFP-10 (Culture Filtrate Protein of 10 kDa), are encoded by genes located within the region of difference 1 (RD1) of the *M. tuberculosis* genome. They are highly immunogenic and not present in the BCG vaccine or most non-tuberculous mycobacteria, making them ideal for detecting *M. tuberculosis*-specific immune responses.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not specify the correct antigens used in IGRA.
- **Option B:** This option is incorrect as it does not accurately represent the antigens targeted by IGRA.
- **Option D:** This option is incorrect because it does not list the specific antigens ESAT-6, CFP-10, and TB7.7.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that IGRA tests, such as the QuantiFERON and T-SPOT.TB assays, are used to detect IFN-γ release in response to ESAT-6, CFP-10, and TB7.7, among other antigens. These tests are particularly useful in individuals who have received BCG vaccination, as they can help differentiate between BCG-induced immunity and *M. tuberculosis* infection.

## **Correct Answer:** . ESAT-6, CFP-10, and TB7.7